Human Study to Develop a Signature of Occupational Diesel Exhaust Exposure
DICE
A Controlled Dose-Response Human Study to Develop a Signature of Occupational Diesel Exhaust Exposure
1 other identifier
interventional
20
1 country
1
Brief Summary
Strong scientific understanding of how emissions from diesel engines impact the lungs could improve policies and regulations protecting workers exposed to diesel exhaust. Accordingly, we are recruiting healthy volunteers who are non-smokers to participate in our study. Volunteers sit in a room for four hours and breathe either clean filtered air or air that contains pollution at various concentrations similar to occupational settings such as bus and ferry terminals where diesel engines are used. A respirologist assesses the volunteer's lung health and clinical samples are taken. We are equipped with advanced molecular biology tools to measure different molecules and compare samples from our volunteer subjects following exposure to clean air or diesel exhaust. Our research aim is to find a simple, clinically relevant strategy that can be used to measure the impact of diesel exhaust on workers' lung health. This knowledge will empower regulators, companies, and ultimately workers to better manage their health risks. Our research aims to provide specific data to help regulators to make informed decisions about the risks of diesel exhaust exposure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2017
CompletedFirst Posted
Study publicly available on registry
July 31, 2017
CompletedStudy Start
First participant enrolled
September 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 16, 2021
CompletedNovember 2, 2021
October 1, 2021
3.8 years
July 25, 2017
October 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum proteome in response to DE exposure
Serum from each experimental condition will be analyzed by liquid chromatography-mass spectrometry (LC-MS/MS) to observe any changes between the baseline and listed time points
4 hours & 24 hours
Secondary Outcomes (3)
Urine proteins in response to DE exposure
4 hours & 24 hours
Polycyclic Aromatic Hydrocarbons (PAH) metabolites in response to DE exposure
4 hours & 24 hours
Sleep quality
baseline versus 24 hours post-exposure
Study Arms (2)
Filtered Air Exposure
ACTIVE COMPARATORExposure for 4 hours to filtered air
Diesel Exhaust Exposure
EXPERIMENTALVolunteers exposed to different concentrations of diesel exhaust
Interventions
Diesel exposure to different concentrations at different times: 20, 50 and 150ug/m3
Eligibility Criteria
You may qualify if:
- years
- Non-smokers
- No physician diagnosed asthma
You may not qualify if:
- Pregnant/breastfeeding
- Using inhaled corticosteroids
- Co-existing medical conditions (as assessed by the primary investigator)
- Taking part in another study that involves taking medications.
- Abnormal lung function based on screening spirometry
- Cardiac diagnosis or arrhythmia is discovered during the screening process
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- Government of Albertacollaborator
- Ottawa Hospital Research Institutecollaborator
Study Sites (1)
University of British Columbia - VGH site
Vancouver, British Columbia, V5Z 1M9, Canada
Related Publications (4)
Guest PC, Gottschalk MG, Bahn S. Proteomics: improving biomarker translation to modern medicine? Genome Med. 2013 Feb 27;5(2):17. doi: 10.1186/gm421. eCollection 2013. No abstract available.
PMID: 23445684BACKGROUNDHuang W, Smith TJ, Ngo L, Wang T, Chen H, Wu F, Herrick RF, Christiani DC, Ding H. Characterizing and biological monitoring of polycyclic aromatic hydrocarbons in exposures to diesel exhaust. Environ Sci Technol. 2007 Apr 15;41(8):2711-6. doi: 10.1021/es062863j.
PMID: 17533828BACKGROUNDMorgott DA. Factors and Trends Affecting the Identification of a Reliable Biomarker for Diesel Exhaust Exposure. Crit Rev Environ Sci Technol. 2014 Aug;44(16):1795-1864. doi: 10.1080/10643389.2013.790748.
PMID: 25170242BACKGROUNDOrach J, Rider CF, Yuen ACY, Schwartz C, Mookherjee N, Carlsten C. Controlled Diesel Exhaust Exposure Induces a Concentration-dependent Increase in Airway Inflammation: A Clinical Trial. Ann Am Thorac Soc. 2023 Jun;20(6):834-842. doi: 10.1513/AnnalsATS.202209-762OC.
PMID: 36930796DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Carlsten, MD, MPH
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 25, 2017
First Posted
July 31, 2017
Study Start
September 27, 2017
Primary Completion
July 16, 2021
Study Completion
July 16, 2021
Last Updated
November 2, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share